– USA, CA – The Beauty Health Company (NASDAQ: SKIN) announced the appointment of Stephen Fanning to its Board of Directors, effective as of December 12, 2024, bringing the Board to eight members.
Mr. Fanning will join the Nominating & Corporate Governance Committee and the Audit Committee.
About Stephen J Fanning
Stephen Fanning brings decades of global medical aesthetics experience, including serving as Hydrafacial’s Chairman of the Board from 2016 to 2020, before the Company’s IPO. He was recently President and CEO of Spectrum Solutions, a molecular diagnostics firm, and previously led Z-Medica, boosting sales and EBITDA before its acquisition by Linden Capital. Mr. Fanning also headed Solta Medical, known for Thermage and Fraxel, and held leadership roles at Ocular Sciences and Johnson & Johnson, driving international growth. Today, Mr. Fanning serves as Chairman of the Board for Champion Manufacturing and LKC Technologies.
About The Beauty Health Company
The Beauty Health Company is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial in hydradermabrasion, SkinStylus in microneedling, and Keravive in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet.
For more information: https://www.beautyhealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.